A Prospective obsERvational Study to asSEss the Effectiveness of Intravitreal Aflibercept Injection in roUtine Clinical Practice in Treatment Naive patientS With Wet Age-related Macular Degeneration in Greece
Phase of Trial: Phase IV
Latest Information Update: 05 Jun 2017
At a glance
- Drugs Aflibercept (Primary)
- Indications Wet age-related macular degeneration
- Focus Therapeutic Use
- Acronyms PERSEUS-GR
- Sponsors Bayer
- 29 May 2017 Planned primary completion date changed from 30 Dec 2018 to 15 Mar 2019.
- 26 Sep 2016 Planned End Date changed from 1 Dec 2018 to 1 Mar 2019.
- 29 Jul 2016 Status changed from not yet recruiting to recruiting.